COMPARISON OF PERGOLIDE AND BROMOCRIPTINE THERAPY IN PARKINSONISM

被引:114
作者
LEWITT, PA
WARD, CD
LARSEN, TA
RAPHAELSON, MI
NEWMAN, RP
FOSTER, N
DAMBROSIA, JM
CALNE, DB
机构
[1] NINCDS,OFF BIOMETRY & FIELD STUDIES,BETHESDA,MD 20205
[2] NINCDS,EXPTL THERAPEUT BRANCH,BETHESDA,MD 20205
关键词
D O I
10.1212/WNL.33.8.1009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1009 / 1014
页数:6
相关论文
共 38 条
  • [31] CENTRAL EFFECTS OF A NOVEL DOPAMINE AGONIST
    SETLER, PE
    SARAU, HM
    ZIRKLE, CL
    SAUNDERS, HL
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 50 (04) : 419 - 430
  • [32] PERGOLIDE MESYLATE AND IDIOPATHIC PARKINSON DISEASE
    TANNER, CM
    GOETZ, CG
    GLANTZ, RH
    GLATT, SL
    KLAWANS, HL
    [J]. NEUROLOGY, 1982, 32 (10) : 1175 - 1179
  • [33] TANNER CM, 1982, NEUROLOGY, V32, pA65
  • [34] CROSS TOLERANCE BETWEEN 2 DOPAMINERGIC ERGOT DERIVATIVES - BROMOCRIPTINE AND LERGOTRILE
    TEYCHENNE, PF
    ROSIN, AJ
    PLOTKIN, CN
    CALNE, DB
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (01) : 47 - 50
  • [35] TEYCHENNE PF, 1979, GASTROENTEROLOGY, V76, P575
  • [36] COMPARISON BETWEEN LERGOTRILE AND BROMOCRIPTINE IN PARKINSONISM
    TEYCHENNE, PF
    PFEIFFER, RF
    BERN, SM
    MCINTURFF, D
    CALNE, DB
    [J]. ANNALS OF NEUROLOGY, 1978, 3 (04) : 319 - 324
  • [37] THORNER MO, 1983, LISURIDE OTHER DOPAM, P213
  • [38] EFFECTS OF BROMOCRIPTINE ON CENTRAL DOPAMINERGIC RECEPTORS
    TRABUCCHI, M
    SPANO, PF
    TONON, GC
    FRATTOLA, L
    [J]. LIFE SCIENCES, 1976, 19 (02) : 225 - 231